Rep. Sydney Kamlager-Dove (D-Calif.) urged the Drug Enforcement Administration (DEA) to refute any assertions that suggested rescheduling marijuana at the federal level would breach international treaty obligations. In a letter to DEA administrator Anne Milgram, Kamlager-Dove stressed international treaties neither mandate the inclusion of marijuana in Schedule I or II of the Controlled Substance Act (CSA) nor preclude the DEA from embracing the Schedule III reclassification recommended by the U.S. Department of Health and Human Services (HHS) in August 2023. “I write to urge you to reject any…
